Drug
AK138D1
AK138D1 is a pharmaceutical drug with 4 clinical trials. Currently 3 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(75%)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting3
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
recruiting375%
not_yet_recruiting125%
Recent Activity
3 active trials
Showing 4 of 4
recruitingphase_1
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer
NCT07623356
not_yet_recruitingphase_1
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
NCT07560124
recruitingphase_1
A Study of AK138D1 in Advanced Malignant Tumors
NCT07281326
recruitingphase_1
A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
NCT06730386
Clinical Trials (4)
Showing 4 of 4 trials
NCT07623356Phase 1
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer
NCT07560124Phase 1
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
NCT07281326Phase 1
A Study of AK138D1 in Advanced Malignant Tumors
NCT06730386Phase 1
A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4